alpha2C Adrenergic Receptors & Cutaneous Circulation
α2C 肾上腺素能受体
基本信息
- 批准号:7383892
- 负责人:
- 金额:$ 34.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenergic ReceptorAffectArteriesBlood CirculationBlood flowCell surfaceCellsClosureConstriction procedureCutaneousCyclic AMPDataDiseaseExposure toGTP-Binding ProteinsGenerationsGolgi ApparatusHeat LossesHumanKnockout MiceLocalizedMediatingMitochondriaModelingMusNorepinephrineOxidation-ReductionPathogenesisPathway interactionsPhenotypePhosphotransferasesPhysiologicalPrincipal InvestigatorRNA InterferenceRaynaud DiseaseRaynaud PhenomenonReceptor Protein-Tyrosine KinasesRegulationRho-associated kinaseRoleSerumSignal PathwaySignal TransductionSkinTailTransactTransactivationTyrosineTyrosine Kinase InhibitorVasospasmchemotherapeutic agentinhibitor/antagonistnovelpreventresponsewarm temperature
项目摘要
DESCRIPTION (provided by applicant): During cold exposure, cutaneous blood flow is reduced to prevent heat loss. This is mediated by increased sympathetic tone and a cold-induced sensitization of cutaneous arteries to constriction by norepinephrine. The latter effect is mediated by cold-induced amplification of (alpha2-adrenergic receptor (alpha2-AR) function. Although alpha2-ARs comprise 3 subtypes, only alpha2C-ARs respond to cold. Although alpha2C-ARs are not functional at 37 degrees C, they are entirely responsible for the cold-induced amplification of alpha2-AR constriction. At 37 degrees C, alpha2C-ARs are retained in the transGolgi network. Cooling causes alpha2C-AR translocation to the cell surface where they can respond to stimulation. The functional rescue of alpha2C-ARs is mediated by cold-induced activation of RhoA and rho kinase (ROCK). ROCKI inhibition by pharmacological blockade or RNA interference prevents cold-induced mobilization of alpha2C-ARs and cold-induced constriction in cutaneous arteries. We now demonstrate that cooling of tail arteries causes a rapid increase in ROS activity in VSM mitochondria, which precedes RhoA activation. Indeed, inhibition of ROS activity abolished cold-induced activation of RhoA and the functional rescue of alpha2C-ARs. The rescue of alpha2C-ARs was also reduced by a tyrosine kinase inhibitor. We propose that cold stimulates mitochondrial generation of ROS, causing transactivation of a receptor tyrosine kinase and activation of RhoA/ROCKI, enabling the spatial and functional rescue of alpha2C-ARs. We have also identified a novel cyclic AMP signaling pathway in cutaneous VSMs, which activates Rapl and causes profound increases in alpha2C-AR expression. We propose that these novel pathways for regulating the function and expression alpha2C-ARs may contribute to cold-induced vasospasm. Indeed, we present a new model of cold-induced vasospasm, generated by a chemotherapeutic agent that causes Raynaud's Disease in humans. This model displays a selective and dramatic increase in VSM alpha2C-AR activity, which precipitate vasospasm of cutaneous arteries. Three specific aims are proposed to pursue these novel and exciting findings and to investigate their physiological and pathophysiological significance.
描述(由申请人提供):在寒冷暴露期间,皮肤血流量减少以防止热量损失。这是由交感神经张力增加和寒冷引起的皮肤动脉对去甲肾上腺素收缩的敏感性介导的。后一种效应是通过寒冷诱导的α2-肾上腺素能受体(α2-AR)功能放大介导的。尽管α2-AR包含3种亚型,但只有α2C-AR对寒冷有反应。尽管α2C-AR在37摄氏度下不起作用,它们完全负责冷诱导的 α2-AR 收缩放大。在 37 摄氏度时,α2C-AR 保留在反高尔基体中。冷却导致 alpha2C-AR 易位到细胞表面,在细胞表面,α2C-AR 的功能性拯救是通过药理学阻断或 RNA 干扰诱导的 RhoA 和 rho 激酶 (ROCK) 抑制介导的。防止冷诱导的 alpha2C-AR 动员和冷诱导的皮肤动脉收缩 我们现在证明,尾动脉冷却会导致 VSM 线粒体中 ROS 活性快速增加。事实上,ROS 活性的抑制消除了冷诱导的 RhoA 激活和 alpha2C-AR 的功能拯救。酪氨酸激酶抑制剂也减少了 α2C-AR 的拯救。我们认为寒冷会刺激线粒体产生 ROS,引起受体酪氨酸激酶的反式激活和 RhoA/ROCKI 的激活,从而实现 alpha2C-AR 的空间和功能拯救。我们还在皮肤 VSM 中发现了一种新的环 AMP 信号通路,该通路激活 Rapl 并导致 alpha2C-AR 表达显着增加。我们提出,这些调节 alpha2C-AR 功能和表达的新途径可能有助于寒冷诱导的血管痉挛。事实上,我们提出了一种由寒冷引起的血管痉挛的新模型,该模型是由导致人类雷诺氏病的化疗药物产生的。该模型显示 VSM α2C-AR 活性选择性显着增加,从而引发皮肤动脉血管痉挛。提出了三个具体目标来追求这些新颖且令人兴奋的发现并研究其生理和病理生理学意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICHOLAS A FLAVAHAN其他文献
NICHOLAS A FLAVAHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICHOLAS A FLAVAHAN', 18)}}的其他基金
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
内皮成熟受损和血管疾病的发育起源
- 批准号:
8759467 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
内皮成熟受损和血管疾病的发育起源
- 批准号:
9279232 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
内皮成熟受损和血管疾病的发育起源
- 批准号:
9085330 - 财政年份:2014
- 资助金额:
$ 34.99万 - 项目类别:
Endothelial exocytosis and the vascular dysfunction of aging
内皮胞吐作用与衰老的血管功能障碍
- 批准号:
8059698 - 财政年份:2010
- 资助金额:
$ 34.99万 - 项目类别:
Endothelial exocytosis and the vascular dysfunction of aging
内皮胞吐作用与衰老的血管功能障碍
- 批准号:
7878227 - 财政年份:2010
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7390919 - 财政年份:2006
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7422526 - 财政年份:2006
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7635844 - 财政年份:2005
- 资助金额:
$ 34.99万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7255586 - 财政年份:2005
- 资助金额:
$ 34.99万 - 项目类别:
alpha2C Adrenergic Receptors & Cutaneous Circulation
α2C 肾上腺素能受体
- 批准号:
6903241 - 财政年份:2005
- 资助金额:
$ 34.99万 - 项目类别:
相似国自然基金
Irisin调控IGFBP-7泛素化对肺动脉高压肺血管重构影响的机制研究
- 批准号:82300070
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TGF-β1通过下调ALKBH5影响 m6A RNA甲基化抑制子宫螺旋动脉平滑肌细胞表型转换的机制研究
- 批准号:32300719
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ABHD17a调控PPARγ棕榈酰化修饰影响泡沫细胞形成和动脉粥样硬化发展的机制研究
- 批准号:82301972
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于HIF-1α/NLRP3通路探讨低氧性肺动脉高压铁代谢失调对PASMCs焦亡的影响及肺心汤干预
- 批准号:82305214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
IRF6通过IFN-α/β-JAK1-STAT1-BNIP3L轴调控线粒体自噬促进平滑肌细胞铁死亡影响主动脉夹层的作用和机制研究
- 批准号:82370487
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease Modeling
开发基于胶原蛋白的 3D 生物打印微流体平台,用于血管组织工程和疾病建模
- 批准号:
10837289 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Alpha Adrenergic Methylation and Developmental Maturation of Cerebral Autoregulation in Ovine Preterm Fetus
羊早产儿的α肾上腺素能甲基化和大脑自动调节的发育成熟
- 批准号:
10661985 - 财政年份:2023
- 资助金额:
$ 34.99万 - 项目类别:
Human Resistance Artery Functional Changes with Alcohol Use
饮酒后人体阻力动脉功能的变化
- 批准号:
10589888 - 财政年份:2022
- 资助金额:
$ 34.99万 - 项目类别:
Human Resistance Artery Functional Changes with Alcohol Use
饮酒后人体阻力动脉功能的变化
- 批准号:
10372624 - 财政年份:2022
- 资助金额:
$ 34.99万 - 项目类别:
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease Modeling
开发基于胶原蛋白的 3D 生物打印微流体平台,用于血管组织工程和疾病建模
- 批准号:
10468156 - 财政年份:2021
- 资助金额:
$ 34.99万 - 项目类别: